On 2025-05-13, Spero Therapeutics, Inc. (SPRO) announced earnings per share of $-0.25 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.55.
The next expected annoucement date for quarterly earnings is 2025-08-04, with an average estimated earnings per share of $-0.35 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.55 | $-0.25 |
| 2025-03-27 | 2024-12-31 | $-0.35 | $-0.38 |
| 2024-11-14 | 2024-09-30 | $-0.27 | $-0.32 |
| 2024-08-05 | 2024-06-30 | $-0.35 | $-0.33 |
| 2024-05-15 | 2024-03-31 | $-0.07 | $-0.24 |
| 2024-03-13 | 2023-12-31 | $-0.18 | $0.96 |
| 2023-11-13 | 2023-09-30 | $-0.15 | $0.02 |
| 2023-08-10 | 2023-06-30 | $-0.29 | $-0.23 |
| 2023-05-11 | 2023-03-31 | $-0.35 | $-0.25 |
| 2023-03-30 | 2022-12-31 | $-0.40 | $0.55 |
| 2022-11-14 | 2022-09-30 | $-0.34 | $-0.33 |
| 2022-08-10 | 2022-06-30 | $-0.88 | $-0.87 |
| 2022-05-16 | 2022-03-31 | $-0.87 | $-1.01 |
| 2022-03-31 | 2021-12-31 | $-0.80 | $-0.90 |
| 2021-11-10 | 2021-09-30 | $-0.70 | $-0.70 |
| 2021-08-05 | 2021-06-30 | $-0.77 | $-0.63 |
| 2021-05-06 | 2021-03-31 | $-0.61 | $-0.66 |
| 2021-03-11 | 2020-12-31 | $-0.77 | $-0.68 |
| 2020-11-05 | 2020-09-30 | $-0.91 | $-0.86 |
| 2020-08-06 | 2020-06-30 | $-1.17 | $-0.85 |
| 2020-05-08 | 2020-03-31 | $-1.35 | $-1.22 |
| 2020-03-16 | 2019-12-31 | $-1.09 | $-1.32 |
| 2019-11-04 | 2019-09-30 | $-0.80 | $-0.95 |
| 2019-08-08 | 2019-06-30 | $-0.57 | $-0.74 |
| 2019-05-09 | 2019-03-31 | $-0.77 | $-0.29 |
| 2019-03-14 | 2018-12-31 | $-0.76 | $-0.60 |
| 2018-11-08 | 2018-09-30 | $-0.64 | $-0.60 |
| 2018-08-09 | 2018-06-30 | $-0.88 | $-0.69 |
| 2018-05-10 | 2018-03-31 | $-1.31 | $-0.74 |
| 2018-04-02 | 2017-12-31 | -- | $-1.59 |
| 2017-12-14 | 2017-09-30 | $-2.44 | $-36.02 |